INDIANAPOLIS and ATLANTA, Dec. 14, 2017 /PRNewswire/ — Rimidi, a digital health company that provides software and clinical analytics for chronic disease management, and Eli Lilly and Company (NYSE: LLY), a leader in diabetes care for more than 90 years, are coming together to develop…
